The glycosylated gag protein of MuLV is a determinant of neuroinvasiveness: analysis of second site revertants of a mutant MuLV lacking expression of this protein - PubMed (original) (raw)
. 1996 Dec 15;226(2):384-92.
doi: 10.1006/viro.1996.0666.
Affiliations
- PMID: 8955058
- DOI: 10.1006/viro.1996.0666
Free article
The glycosylated gag protein of MuLV is a determinant of neuroinvasiveness: analysis of second site revertants of a mutant MuLV lacking expression of this protein
J L Portis et al. Virology. 1996.
Free article
Abstract
Neuroinvasiveness is a property of all neurovirulent murine retroviruses, although the factors which facilitate infection of the CNS are not understood. We previously showed that mutant MuLV which lack expression of an accessory protein, glycosylated gag, had lost neurovirulence, indicating that this protein may be involved in promoting CNS infection. The mutations were located in the "Kozak" consensus sequence of the initiation codon for this protein. Here it is shown that shortly after inoculation of mice with one of these mutant viruses, revertants emerged which had regained expression of glycosylated gag and had also regained the neuroinvasiveness and neurovirulence exhibited by the wild-type virus. The phenotypic revertants retained the mutations in the "Kozak" consensus sequence but exhibited a G-->A mutation 12 codons downstream from the mutated start site, creating a new initiation codon and a glycosylated gag protein, which was truncated at its N-terminus. Using antibodies specific for glycosylated gag it is shown that the frequency of splenic infectious centers expressing revertant virus increased progressively during the 2 months following inoculation of mutant virus until > or = 50% of the virus-producing cells in the spleen expressed revertant virus. In contrast, although phenotypic revertants were detectable at low frequency after cell-free passage in vitro in M. dunni fibroblasts, there was no evidence for selection. These results indicate that glycosylated gag facilitates virus spread within the spleen and to extra-splenic sites, such as the CNS, and suggest that the protein may function through its interaction with the host.
Similar articles
- Biological characterization and molecular cloning of murine C-type retroviruses derived from the TSZ complex from mainland China.
Bundy LM, Ru M, Zheng BF, Cheng L, Pattengale PK, Portis JL, Fan H. Bundy LM, et al. Virology. 1995 Oct 1;212(2):367-82. doi: 10.1006/viro.1995.1494. Virology. 1995. PMID: 7571406 - Mutation in the glycosylated gag protein of murine leukemia virus results in reduced in vivo infectivity and a novel defect in viral budding or release.
Low A, Datta S, Kuznetsov Y, Jahid S, Kothari N, McPherson A, Fan H. Low A, et al. J Virol. 2007 Apr;81(8):3685-92. doi: 10.1128/JVI.01538-06. Epub 2007 Jan 31. J Virol. 2007. PMID: 17267509 Free PMC article. - Operating under a Gag order: a block against incoming virus by the Fv1 gene.
Goff SP. Goff SP. Cell. 1996 Sep 6;86(5):691-3. doi: 10.1016/s0092-8674(00)80141-5. Cell. 1996. PMID: 8797814 Review. No abstract available. - Molecular analysis and characterization of two myeloid leukemia inducing murine retroviruses.
Rassart E, Houde J, Denicourt C, Ru M, Barat C, Edouard E, Poliquin L, Bergeron D. Rassart E, et al. Curr Top Microbiol Immunol. 1996;211:201-10. doi: 10.1007/978-3-642-85232-9_20. Curr Top Microbiol Immunol. 1996. PMID: 8585951 Review. No abstract available.
Cited by
- Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins.
Ahi YS, Zhang S, Thappeta Y, Denman A, Feizpour A, Gummuluru S, Reinhard B, Muriaux D, Fivash MJ, Rein A. Ahi YS, et al. mBio. 2016 Nov 22;7(6):e01985-16. doi: 10.1128/mBio.01985-16. mBio. 2016. PMID: 27879338 Free PMC article. - Pushing the limits of the scanning mechanism for initiation of translation.
Kozak M. Kozak M. Gene. 2002 Oct 16;299(1-2):1-34. doi: 10.1016/s0378-1119(02)01056-9. Gene. 2002. PMID: 12459250 Free PMC article. Review. - N-terminal cleavage fragment of glycosylated Gag is incorporated into murine oncornavirus particles.
Fujisawa R, McAtee FJ, Favara C, Hayes SF, Portis JL. Fujisawa R, et al. J Virol. 2001 Nov;75(22):11239-43. doi: 10.1128/JVI.75.22.11239-11243.2001. J Virol. 2001. PMID: 11602765 Free PMC article. - Characterization of glycosylated Gag expressed by a neurovirulent murine leukemia virus: identification of differences in processing in vitro and in vivo.
Fujisawa R, McAtee FJ, Zirbel JH, Portis JL. Fujisawa R, et al. J Virol. 1997 Jul;71(7):5355-60. doi: 10.1128/JVI.71.7.5355-5360.1997. J Virol. 1997. PMID: 9188605 Free PMC article. - Moloney murine leukemia virus glyco-gag facilitates xenotropic murine leukemia virus-related virus replication through human APOBEC3-independent mechanisms.
Nitta T, Lee S, Ha D, Arias M, Kozak CA, Fan H. Nitta T, et al. Retrovirology. 2012 Jul 24;9:58. doi: 10.1186/1742-4690-9-58. Retrovirology. 2012. PMID: 22828015 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical